Tubulin Inhibiting Agent [EPC]

291 reported adverse events

Drugs of this class: GRISEOFULVIN ULTRAMICROSIZE GRISEOFULVIN GRISEOFULVIN (MICROSIZE) GRISOFULVIN ULTRAMICROSIZE GRISEOFULVIN TABLETS

These side effects are most commonly reported by patients taking drugs of the Tubulin Inhibiting Agent [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 39
1 HEADACHE 16
2 OFF LABEL USE 14
3 RASH 13
4 PYREXIA 11
5 DIARRHOEA 10
6 DRUG HYPERSENSITIVITY 10
7 PAIN 10
8 PATHOGEN RESISTANCE 10
9 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9
See all common reactions for Tubulin Inhibiting Agent [EPC]

Drugs of the Tubulin Inhibiting Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARD9 DEFICIENCY 4 1.0000
1 ADENOSINE DEAMINASE DEFICIENCY 1 1.0000
2 TRICHOPHYTIC GRANULOMA 2 0.0426
3 TINEA CAPITIS 2 0.0174
4 DERMATOPHYTOSIS 3 0.0106
5 TRICHOPHYTOSIS 2 0.0094
6 PITYRIASIS RUBRA PILARIS 2 0.0084
7 BREAST INFECTION 1 0.0083
8 ANASTOMOTIC ULCER HAEMORRHAGE 1 0.0070
9 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 1 0.0065
See all enriched reactions for Tubulin Inhibiting Agent [EPC]